Hinge Health (NYSE:HNGE) Reaches New 12-Month High After Analyst Upgrade

Key Points

• Hinge Health shares reached a new 52-week high of $57.10 after Evercore ISI raised its price target for the stock from $50 to $60, maintaining an outperform rating.
• Multiple brokerages have raised their target prices on Hinge Health, with Needham & Company increasing theirs from $47 to $59 and Stifel Nicolaus from $48 to $55, both issuing "buy" ratings.
• Overall, Hinge Health's stock is up 13.3%, with a consensus average rating of "Buy" and a target price of $53.79 among analysts.

Shares of Hinge Health Inc. (NYSE:HNGE - Get Free Report) reached a new 52-week high on Wednesday after Canaccord Genuity Group raised their price target on the stock from $52.00 to $61.00. Canaccord Genuity Group currently has a buy rating on the stock. Hinge Health traded as high as $57.10 and last traded at $54.24, with a volume of 630681 shares traded. The stock had previously closed at $48.22.

Other analysts have also issued reports about the company. Wall Street Zen upgraded Hinge Health to a "hold" rating in a research note on Monday, June 2nd. Citizens Jmp assumed coverage on Hinge Health in a research note on Monday, July 14th. They set a "strong-buy" rating and a $58.00 price objective on the stock. Morgan Stanley boosted their price objective on Hinge Health from $46.00 to $57.00 and gave the company an "overweight" rating in a research note on Wednesday. Royal Bank Of Canada assumed coverage on Hinge Health in a research note on Monday, June 16th. They set an "outperform" rating and a $45.00 price objective on the stock. Finally, Truist Financial assumed coverage on Hinge Health in a research note on Monday, June 16th. They set a "buy" rating and a $48.00 price objective on the stock. One investment analyst has rated the stock with a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, Hinge Health has an average rating of "Buy" and an average price target of $55.71.

Hedge Funds Weigh In On Hinge Health

Institutional investors have recently modified their holdings of the company. PNC Financial Services Group Inc. bought a new position in shares of Hinge Health during the 2nd quarter valued at about $71,000. SBI Securities Co. Ltd. bought a new position in shares of Hinge Health during the 2nd quarter valued at about $48,000. Montag A & Associates Inc. bought a new position in shares of Hinge Health during the 2nd quarter valued at about $41,000. Lisanti Capital Growth LLC bought a new position in Hinge Health during the 2nd quarter worth approximately $3,089,000. Finally, Mark Sheptoff Financial Planning LLC bought a new position in Hinge Health during the 2nd quarter worth approximately $114,000.

Hinge Health Stock Down 5.7%

The stock has a 50-day moving average of $44.44.

About Hinge Health

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.